SCHEMBL7384343

SCHEMBL7384343

Cc1ccc(-c2cscc2Br)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.52
CYP2A6 P11509 2/20 0.42
CYP2B6 P20813 2/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
ALDH1A1 P00352 3/20 0.39
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
NOTUM Q6P988 1/20 0.35
ACHE P22303 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTGS1 P23219 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPK1 P28482 2/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31618738 0.84 PTGS2 (0.67) PTGS2CYP2A6CYP2B6ESR1ESR2
SCHEMBL2037998 0.78 ESR1 (0.71) ESR1ESR2ALDH1A1NPC1RAB9A
SCHEMBL6050649 0.78 PTGS2 (0.56) PTGS2CYP2A6CYP2B6ESR1ESR2
SCHEMBL12422714 0.77 CYP2A6 (0.68) PTGS2CYP2A6CYP2B6ESR1ESR2
SCHEMBL9672144 0.77 CYP2A6 (0.56) PTGS2CYP2A6CYP2B6ESR1ESR2
SCHEMBL31618783 0.76 CYP2A6 (0.65) PTGS2CYP2A6CYP2B6ESR1ESR2
SCHEMBL2036568 0.74 MAOA (0.41) CYP2A6ESR1ESR2ALDH1A1NOTUM
SCHEMBL7253177 0.72 ESR1 (0.33) ESR1ESR2
SCHEMBL13319556 0.72 ALDH1A1 (0.46) PTGS2ALDH1A1NPC1RAB9AKMT2A
SCHEMBL6050693 0.71 PTGS2 (0.72) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5252574-A Hypotensive agents, vision disorder MERCK & CO., INC. (US) 1993-10-12 US disclosed
US-5198438-A ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED THIOPHENE OR FURAN MERCK & CO., INC. (US) 1993-03-30 US disclosed
US-5177074-A Heterocyclic nitrogen compounds used to treat hypertension, cognitive dysfunction, anxiety or depression MERCK & CO., INC. (US) 1993-01-05 US disclosed
EP-0137333-B1 SPIRO-TRICYCLICAROMATIC SUCCINIMIDE DERIVATIVES AS INHIBITORS OF ALDOSE REDUCTASE ALCON LABORATORIES, INC. (US) 1992-12-30 EP disclosed
EP-0513979-A1 Angiotensin II antagonists incorporating a substituted thiophene or furan MERCK & CO. INC. (US) 1992-11-19 EP disclosed
EP-0512675-A1 Angiotensin II antagonists incorporating a substituted thiophene or furan MERCK & CO. INC. (US) 1992-11-11 EP disclosed
EP-0510812-A1 Angiotensin II antagonists incorporating a substituted thiophene or furan MERCK & CO. INC. (US) 1992-10-28 EP disclosed
US-5153211-A Enzyme inhibitors ALCON LABORATORIES, INC. (US) 1992-10-06 US disclosed
US-5070100-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1991-12-03 US disclosed
US-4864028-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1989-09-05 US disclosed
US-4537892-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1985-08-27 US disclosed
EP-0137333-A2 Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase ALCON LABORATORIES, INC. (US) 1985-04-17 EP disclosed